In-Vitro Diagnostics (IVD) Quality Control Market Share and Forecast to 2026

1
In-Vitro Diagnostics (IVD) Quality Control Market
To Reach USD 1229.3 Million By 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
High prevalence of target diseases, unhealthy
lifestyle, product launches, increasing strategic
developments such as partnerships and agreements
are key factors contributing to high CAGR of
In-Vitro Diagnostics (IVD) Quality Control Market
during forecast period. Market Size USD 881.8
Million in 2018, Market Growth - CAGR of 4.3.
Market Trends Product launches and research for
In-Vitro Diagnostics (IVD) Quality Control Market.
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global In-Vitro Diagnostics (IVD)
  Quality Control Market was valued at USD 881.8
  Million in 2018 and is expected to reach USD
  1229.3 Million by year 2026, at a CAGR of 4.3.
• IVD quality controls are tests used to
  authenticate the consistency of IVD testing
  system to confirm precision of test findings and
  assess the influence of factors such as
  environmental conditions and operators
  performance on test results. Key recent
  developments in June 2019, Illumina, Inc.
  announced the launch of VeriSeq NIPT Solution v2,
  a CE-IVD next-generation sequencing (NGS)-based
  approach to noninvasive prenatal testing (NIPT),
  delivers the most comprehensive view of the fetal
  genome compared to other CE-IVD NIPT products.
• Factors including increasing prevalence of
  chronic diseases, launch of new clinical
  laboratories, stringent mandates, as well as
  rising need of early diagnostics by patients
  drive the growth of In-Vitro Diagnostics (IVD)
  Quality Control market.
• Get a Free Sample PDF Report to understand our
  report before you purchase https//www.reportsand
  data.com/sample-enquiry-form/1508

4
Our Approach
Market Summary

• Some of the key players are Agilent Diagnostics,
  Abbott Diagnostics, Becton, Dickson and Company,
  Bio-Rad Laboratories, Inc., and ThermoFisher
  Scientific
• Further key findings from the report suggest
• The American Clinical Laboratory Association
  (ACLA) states that more than 7.5 billion lab
  tests are performed in U.S. annually and 80 of
  clinical decisions are taken after lab testing
• In December 2018, BioMérieux announced its
  culture bottles BACT/ALERT BPA and BPN have
  received 510(k) clearance from the U.S. Food and
  Drug Administration (FDA) for quality control
  testing of leukocyte-reduced apheresis platelet
  (LRAP) units with the BACT/ALERT VIRTUO fully
  automated blood culture system
• In-Vitro Diagnostics (IVD) Quality Control Market
  is fastest growing at a CAGR of 3 in Asia
  Pacific owing to rising incidence of IVD tests in
  developing countries such as India and China due
  to upsurge in number of clinical laboratories,
  global awareness among patientsContinued

5
Our Approach
Market Summary

• Product Type (Revenue, USD Million 20162026)
• Quality Controls
• Whole Blood-based Controls
• Serum-based Controls
• Plasma-based Controls
• Urine-based Controls
• Other IVD Quality Controls
• Data Management Solutions
• Quality Assurance Services
• Manufacturer Type (Revenue, USD Million
  20162026)
• Instrument Manufacturer Controls
• Independent Manufacturer Controls
• Third-party Controls
• Instrument Specific Manufacturer Controls

6
Our Approach
Market Summary

• Application (Revenue, USD Million 20162026)
• Clinical Chemistry
• Immunochemistry
• Haematology
• Molecular Diagnostics
• Coagulation/Haemostasis
• Microbiology
• Others
• End User (Revenue, USD Million 20162026)
• Hospitals
• Clinical Laboratories
• Home Care
• Others
• Order Now _at_ https//www.reportsanddata.com/checkou
  t-form/1508

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com